Evolent Health, INC. (EVH) — 10-Q Filings

10-Q Filings (6)

• Evolent Health's Net Loss Widens to $150M Amid Revenue Decline — Nov 7, 2025 Risk: high
  Evolent Health, Inc. (EVH) reported a significant increase in net loss attributable to common shareholders, reaching $150.27 million for the nine months ended S
• Evolent Health's Q2 Net Loss Widens to $26.3M Amid Revenue Surge — Aug 11, 2025 Risk: high
  Evolent Health, Inc. (EVH) reported a net loss of $26.3 million for the three months ended June 30, 2025, a significant increase from the $2.9 million net loss
• Evolent Health Files Q1 2025 10-Q — May 9, 2025 Risk: low
  Evolent Health, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates. Key financial data p
• Evolent Health Files Q3 2024 10-Q Report — Nov 8, 2024 Risk: medium
  Evolent Health, Inc. filed its Q3 2024 10-Q report on November 8, 2024, covering the period ending September 30, 2024. The filing details the company's financia
• Evolent Health Files Q2 2024 10-Q — Aug 9, 2024 Risk: medium
  Evolent Health, Inc. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the second quarter
• Evolent Health, Inc. Files 10-Q for Q1 2024 — May 10, 2024 Risk: medium
  Evolent Health, Inc. (EVH) filed a Quarterly Report (10-Q) with the SEC on May 10, 2024. Evolent Health, Inc. filed its 10-Q report for the period ending March

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX